EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Pharmacy compounded pilocarpine: An adequate solution to overcome shortage of pilogel® discs for sweat testing in patients with cystic fibrosis

P Mian, J M Maurer, D J Touw, M J Vos, B L Rottier

Journal of Cystic Fibrosis · 2024

DOI: 10.1016/j.jcf.2023.09.014 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cystic Fibrosis, 2024. Verfasst von P Mian und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Pharmacy and Pharmacology, University Medical Centre Groningen, University of Groningen, Groningen, the Netherlands. Electroni…. Hauptthemen laut MEDLINE: Cystic Fibrosis, Pharmacy. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 9 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

To respond to shortage of pilocarpine discs due to CE-licensing problems a pharmacy compounded pilocarpine HCL solution was developed and validated for use in CF diagnosis. The aim of this study was to compare the results from a pharmacy compounded pilocarpine HCL solution versus Pilogel® discs for the measurements of sweat chloride concentrations. Ten pediatric and adult patients with CF underwent a sweat test using both Pilogel® discs and pilocarpine HCL solution. The average difference between both methods was -3.25 mmol/L (95% Limits of Agreement: -7.19 [95% CI: -9.19;-5.19] and 0.69 [95% CI: -1.31;2.69] mmol/L. Passing-Bablok regression showed that zero was enclosed with the 95% CI of the calculated intercept (0.15 [95% CI: -1.70;1.42] mmol/L). These data show a good agreement in chloride concentrations obtained using the two pilocarpine products. Therefore, the pharmacy compounded pilocarpine HCL solution can be used as an alternative for Pilogel® discs during times of shortage.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cystic FibrosisPharmacyAdultChildHumansSweatPilocarpineChlorides

Stichwörter der Autor:innen

Cystic fibrosisPilocarpine

Substanzen

PilocarpineChlorides

Autor:innen und Institutionen

  • Department of Clinical Pharmacy and Pharmacology, University Medical Centre Groningen, University of Groningen, Groningen, the Netherlands. Electronic address: p.mian@umcg.nl.
  • Department of Clinical Pharmacy and Pharmacology, University Medical Centre Groningen, University of Groningen, Groningen, the Netherlands.
  • Department of Clinical Pharmacy and Pharmacology, University Medical Centre Groningen, University of Groningen, Groningen, the Netherlands; Department of Pharmaceutical Analysis, Groningen Research Institute of Pharmacy…
  • Laboratory Medicine, University Medical Centre Groningen, University of Groningen, Groningen, the Netherlands.
  • Department of Pediatric Pulmonology and Pediatric Allergology, Beatrix Children's Hospital, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands; Groningen Research Institute for Asth…

Zitieren

APA

Mian, P., Maurer, J. M., Touw, D. J., Vos, M. J., & Rottier, B. L. (2024). Pharmacy compounded pilocarpine: An adequate solution to overcome shortage of pilogel® discs for sweat testing in patients with cystic fibrosis. Journal of Cystic Fibrosis. https://doi.org/10.1016/j.jcf.2023.09.014

Vancouver

Mian P, Maurer JM, Touw DJ, Vos MJ, Rottier BL. Pharmacy compounded pilocarpine: An adequate solution to overcome shortage of pilogel® discs for sweat testing in patients with cystic fibrosis. Journal of Cystic Fibrosis. 2024. doi:10.1016/j.jcf.2023.09.014

BibTeX
@article{Mian2024,
  author = {Mian, P and Maurer, J M and Touw, D J and Vos, M J and Rottier, B L},
  title = {Pharmacy compounded pilocarpine: An adequate solution to overcome shortage of pilogel® discs for sweat testing in patients with cystic fibrosis},
  journal = {Journal of Cystic Fibrosis},
  year = {2024},
  doi = {10.1016/j.jcf.2023.09.014}
}
Kostenlos starten →